Metraipolis › archive › dc_e491aeada51d

Ibrutinib-Associated Liver Injury in a Patient with Chronic Lymphocytic Leukemia: Clinical Course and Therapeutic Approach — Europe PMC PMID:41440767

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41440767
DOI
10.3390/hematolrep17060069
License (as archived)
solo-consultazione
Archived
2026-11-07T17:46:09.388Z
SHA-256 of the archived text
5b45f9a2043227d795c288938815c02c3cd74a3ed346b04a4cf5222c92e8f04b
Stable URL of this page
https://metraipolis.com/documento/dc_e491aeada51d

How to cite

Ibrutinib-Associated Liver Injury in a Patient with Chronic Lymphocytic Leukemia: Clinical Course and Therapeutic Approach — Europe PMC PMID:41440767 — Europe PMC (en), https://europepmc.org/article/MED/41440767 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e491aeada51d (Metraipolis archive dc_e491aeada51d, sha256 5b45f9a2043227d795c288938815c02c3cd74a3ed346b04a4cf5222c92e8f04b)
BibTeX
@misc{dce491aeada51d,
  title = {Ibrutinib-Associated Liver Injury in a Patient with Chronic Lymphocytic Leukemia: Clinical Course and Therapeutic Approach — Europe PMC PMID:41440767},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41440767},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e491aeada51d; sha256 5b45f9a2043227d795c288938815c02c3cd74a3ed346b04a4cf5222c92e8f04b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41440767. Agents can read the archived copy with the MCP tool read_document.